These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9655703)

  • 1. Additivity of protein and nonprotein inhibitors of lung surfactant activity.
    Wang Z; Notter RH
    Am J Respir Crit Care Med; 1998 Jul; 158(1):28-35. PubMed ID: 9655703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple mechanisms of lung surfactant inhibition.
    Holm BA; Wang Z; Notter RH
    Pediatr Res; 1999 Jul; 46(1):85-93. PubMed ID: 10400140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity.
    Holm BA; Notter RH
    J Appl Physiol (1985); 1987 Oct; 63(4):1434-42. PubMed ID: 3693177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral cell wall lipids of Mycobacterium tuberculosis are inhibitory to surfactant function.
    Wang Z; Schwab U; Rhoades E; Chess PR; Russell DG; Notter RH
    Tuberculosis (Edinb); 2008 May; 88(3):178-86. PubMed ID: 18155644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity and inhibition resistance of a phospholipase-resistant synthetic surfactant in rat lungs.
    Wang Z; Chang Y; Schwan AL; Notter RH
    Am J Respir Cell Mol Biol; 2007 Oct; 37(4):387-94. PubMed ID: 17556674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary importance of zwitterionic over anionic phospholipids in the surface-active function of calf lung surfactant extract.
    Wang Z; Gurel O; Weinbach S; Notter RH
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1049-57. PubMed ID: 9351602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface activity of a synthetic lung surfactant containing a phospholipase-resistant phosphonolipid analog of dipalmitoyl phosphatidylcholine.
    Wang Z; Schwan AL; Lairson LL; O'Donnell JS; Byrne GF; Foye A; Holm BA; Notter RH
    Am J Physiol Lung Cell Mol Physiol; 2003 Sep; 285(3):L550-9. PubMed ID: 12902318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic surface activity of a fully synthetic phospholipase-resistant lipid/peptide lung surfactant.
    Walther FJ; Waring AJ; Hernandez-Juviel JM; Gordon LM; Schwan AL; Jung CL; Chang Y; Wang Z; Notter RH
    PLoS One; 2007 Oct; 2(10):e1039. PubMed ID: 17940603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Content of dipalmitoyl phosphatidylcholine in lung surfactant: ramifications for surface activity.
    Holm BA; Wang Z; Egan EA; Notter RH
    Pediatr Res; 1996 May; 39(5):805-11. PubMed ID: 8726232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dependence of surfactant function on extracellular pH: mechanisms and modifications.
    Haddad IY; Holm BA; Hlavaty L; Matalon S
    J Appl Physiol (1985); 1994 Feb; 76(2):657-62. PubMed ID: 8175575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface properties of sulfur- and ether-linked phosphonolipids with and without purified hydrophobic lung surfactant proteins.
    Chang Y; Wang Z; Schwan AL; Wang Z; Holm BA; Baatz JE; Notter RH
    Chem Phys Lipids; 2005 Oct; 137(1-2):77-93. PubMed ID: 16109391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.
    Seeger W; Grube C; Günther A; Schmidt R
    Eur Respir J; 1993 Jul; 6(7):971-7. PubMed ID: 8370446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung surfactant phospholipids associate with polymerizing fibrin: loss of surface activity.
    Seeger W; Elssner A; Günther A; Krämer HJ; Kalinowski HO
    Am J Respir Cell Mol Biol; 1993 Aug; 9(2):213-20. PubMed ID: 8338688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface properties and sensitivity to protein-inhibition of a recombinant apoprotein C-based phospholipid mixture in vitro--comparison to natural surfactant.
    Seeger W; Thede C; Günther A; Grube C
    Biochim Biophys Acta; 1991 Jan; 1081(1):45-52. PubMed ID: 1991155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biophysical inhibition of synthetic lung surfactants.
    Holm BA; Venkitaraman AR; Enhorning G; Notter RH
    Chem Phys Lipids; 1990 Feb; 52(3-4):243-50. PubMed ID: 2340601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface property changes from interactions of albumin with natural lung surfactant and extracted lung lipids.
    Holm BA; Notter RH; Finkelstein JN
    Chem Phys Lipids; 1985 Sep; 38(3):287-98. PubMed ID: 3841303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of biophysical activity of lung surfactant extracts and phospholipid-apoprotein mixtures by surfactant protein A.
    Venkitaraman AR; Hall SB; Whitsett JA; Notter RH
    Chem Phys Lipids; 1990 Dec; 56(2-3):185-94. PubMed ID: 2095991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of albumin and erythrocyte membranes on spread monolayers of lung surfactant lipids.
    Rachana R; Banerjee R
    Colloids Surf B Biointerfaces; 2006 Jun; 50(1):9-17. PubMed ID: 16650737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of surfactant activity by Pneumocystis carinii organisms and components in vitro.
    Wang Z; Foye A; Chang Y; Chess PR; Wright TW; Bhagwat S; Gigliotti F; Notter RH
    Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1124-31. PubMed ID: 15886399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity and biophysical inhibition resistance of a novel synthetic lung surfactant containing Super-Mini-B DATK peptide.
    Notter RH; Wang Z; Walther FJ
    PeerJ; 2016; 4():e1528. PubMed ID: 26793419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.